Wikidata

(Q106138984)

English

A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19

clinical trial

In more languages

Statements

short name
TRISTARDS (English)
0 references
title
The TRISTARDS Trial - ThRombolysIS Therapy for ARDS A Phase IIb/III Operationally Seamless, Open-label, Randomised, Sequential, Parallel-group Adaptive Study to Evaluate the Efficacy and Safety of Daily Intravenous Alteplase Treatment Given up to 5 Days on Top of Standard of Care (SOC) Compared With SOC Alone, in Patients With Acute Respiratory Distress Syndrome (ARDS) Triggered by COVID-19 (English)
0 references
country
Austria
0 references
Belgium
0 references
Denmark
0 references
France
0 references
Germany
0 references
Italy
0 references
Netherlands
0 references
Portugal
0 references
Spain
0 references
start time
16 December 2020
0 references
end time
29 May 2022
0 references
number of participants
270
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q106138984&oldid=2148682461"